Thanksgiving is finished and it’s full steam ahead.
Or is it ?
It’s going to be noisy week but productive? Let’s wait and see
Next week Congress is putting the MORE act up again and we can’t say it any better than Steve Fox at the cannabis Cannabis Trade Federation
As currently written, the MORE Act would remove cannabis from the federal Controlled Substances Act entirely. It would establish a federal excise tax to support a broad range of programs and services, from job training and reentry services to literacy programs and substance abuse treatment services. It provides for expungements and sentence reviews for past cannabis convictions and prohibits the federal government from denying certain benefits or protections based on cannabis use. It would also ensure that cannabis companies, which have been denied Paycheck Protection Program (PPP) assistance during the pandemic, will be eligible for Small Business Administration loans in the future.
Although the Senate will not have time to take action on this bill during the current session of Congress, it is impossible to overstate the symbolic significance of this vote. The American people have already shown that they want cannabis prohibition to end. It is time for members of Congress to demonstrate that they are listening to them.
NORML have a point too
By advancing the MORE Act, the House of Representatives sends an unmistakable signal that America is ready to close the book marijuana prohibition and end the senseless oppression and fear that this failed policy wreaks on otherwise law-abiding citizens.
Meanwhile in a virtual Vienna this is happening
The medical cannabis industry could be in for one of its biggest symbolic wins in decades if a United Nations vote next week implicitly acknowledges the medical value of the drug.
During its reconvened 63rd session Dec. 2-4, the United Nations Commission on Narcotic Drugs (CND) could – with a simple majority vote in a virtual meeting based in Vienna – accept a World Health Organization (WHO) recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs.
The CND’s adoption of that recommendation could prompt a cascade of positive effects for the industry, justifying medical legalization efforts at national levels around the world and potentially positioning countries to broaden already-established regulations.
Read the full article at
The sound of two hands clapping?
We’ll let you know at the end of next week
If you wish to read more and more and more of the same …